메뉴 건너뛰기




Volumn 15, Issue 5, 2015, Pages 729-731

'The patient': At the center of patient-reported outcomes

Author keywords

decision making; patient reported outcomes; patients; self reported

Indexed keywords

ATTITUDE TO HEALTH; ATTITUDE TO ILLNESS; CLINICAL DECISION MAKING; DRUG TOLERABILITY; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; PATIENT CARE; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PATIENT PREFERENCE; PATIENT SAFETY; PATIENT SATISFACTION; PERSONAL EXPERIENCE; QUALITY OF LIFE; REVIEW; SOCIAL INTERACTION; TREATMENT OUTCOME; TREATMENT RESPONSE; DECISION MAKING; OUTCOME ASSESSMENT; SELF REPORT;

EID: 84942823035     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2015.1077118     Document Type: Review
Times cited : (15)

References (17)
  • 2
    • 10044247109 scopus 로고    scopus 로고
    • Impact of atypical antipsychotic on quality of life in patients with schizophrenia
    • Awad AG, Voruganti LNP. Impact of atypical antipsychotic on quality of life in patients with schizophrenia. CNS Drugs 2004;18:877-93
    • (2004) CNS Drugs , vol.18 , pp. 877-893
    • Awad, A.G.1    Voruganti, L.N.P.2
  • 3
    • 84880811606 scopus 로고    scopus 로고
    • The impact of the newer antipsychotics on patient-reported outcomes in schizophrenia
    • Awad AG, Voruganti LNP. The impact of the newer antipsychotics on patient-reported outcomes in schizophrenia. CNS Drugs 2013;27:625-36
    • (2013) CNS Drugs , vol.27 , pp. 625-636
    • Awad, A.G.1    Voruganti, L.N.P.2
  • 4
    • 42749098792 scopus 로고    scopus 로고
    • Patient-reported outcomes measure: Use in medical product development to support labelling claims
    • US FDA Guidance for industry. Patient-reported outcomes measure: use in medical product development to support labelling claims. Health Qual Life Outcomes 2006;4:79
    • (2006) Health Qual Life Outcomes , vol.4 , pp. 79
    • US FDA Guidance for industry1
  • 5
    • 0031973040 scopus 로고    scopus 로고
    • Quality of life measurement in schizophrenia: Reconciling the question of subjectivity with quest of reliability
    • Voruganti LNP, Heselgrave RS, Awad AG, et al. Quality of life measurement in schizophrenia: reconciling the question of subjectivity with quest of reliability. Psychol Med 1998;28:165-72
    • (1998) Psychol Med , vol.28 , pp. 165-172
    • Voruganti, L.N.P.1    Heselgrave, R.S.2    Awad, A.G.3
  • 6
    • 20344370778 scopus 로고    scopus 로고
    • The subjective/objective dichotomy: Relevance to nosology, research and management
    • Gaebel W, editor. Steinkopff Verlag; Darmstadt
    • Awad AG, Voruganti LNP. The subjective/objective dichotomy: relevance to nosology, research and management. In: Gaebel W, editor. Zukunfts Perspectives in Psychiatries and Psychotherapie. Steinkopff Verlag; Darmstadt: 2002. p. 21-7
    • (2002) Zukunfts Perspectives in Psychiatries and Psychotherapie , pp. 21-27
    • Awad, A.G.1    Voruganti, L.N.P.2
  • 7
    • 33847281876 scopus 로고    scopus 로고
    • Correlation of physician and patient-related quality of life during antipsychotic treatment in outpatients with schizophrenia
    • Wehmeier PM, Kluge M, Schact A, et al. Correlation of physician and patient-related quality of life during antipsychotic treatment in outpatients with schizophrenia. Schizophr Res 2007;91:178-86
    • (2007) Schizophr Res , vol.91 , pp. 178-186
    • Wehmeier, P.M.1    Kluge, M.2    Schact, A.3
  • 8
    • 77950891328 scopus 로고    scopus 로고
    • Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders
    • Awad AG. Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders. Expert Rev Pharmacoecon Outcomes Res 2010;10:1-4
    • (2010) Expert Rev Pharmacoecon Outcomes Res , vol.10 , pp. 1-4
    • Awad, A.G.1
  • 9
    • 33750626892 scopus 로고    scopus 로고
    • Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia: Findings from in vivo SPECT study
    • Voruganti LNP, Awad AG. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia: findings from in vivo SPECT study. Schizophr Res 2006;88:179-86
    • (2006) Schizophr Res , vol.88 , pp. 179-186
    • Voruganti, L.N.P.1    Awad, A.G.2
  • 10
    • 0034130233 scopus 로고    scopus 로고
    • Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone
    • De Haan L, Lavalaye J, Linszend D, et al. Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am J Psychiatry 2000;157:1019-20
    • (2000) Am J Psychiatry , vol.157 , pp. 1019-1020
    • De Haan, L.1    Lavalaye, J.2    Linszend, D.3
  • 11
    • 69749124350 scopus 로고    scopus 로고
    • The relationship between subjective well-being and dopamine D2 receptors and a full antagonist antipsychotic
    • Mizrahi R, Mamo D, Pausion P, et al. The relationship between subjective well-being and dopamine D2 receptors and a full antagonist antipsychotic. Int J Neuropsychopharmacology 2009;5:715-21
    • (2009) Int J Neuropsychopharmacology , vol.5 , pp. 715-721
    • Mizrahi, R.1    Mamo, D.2    Pausion, P.3
  • 12
    • 84857320694 scopus 로고    scopus 로고
    • Measuring quality of life in patients with schizophrenia - An update
    • Awad AG, Voruganti LNP. Measuring quality of life in patients with schizophrenia - an update. Pharmacoeconomics 2012;30:183-95
    • (2012) Pharmacoeconomics , vol.30 , pp. 183-195
    • Awad, A.G.1    Voruganti, L.N.P.2
  • 14
    • 79959464114 scopus 로고    scopus 로고
    • The importance of measuring social functioning in schizophrenia
    • Brissos S, Molodynski A, Dias V, et al. The importance of measuring social functioning in schizophrenia. Ann Gen Psychiatry 2011;10:1-7
    • (2011) Ann Gen Psychiatry , vol.10 , pp. 1-7
    • Brissos, S.1    Molodynski, A.2    Dias, V.3
  • 15
    • 84942820402 scopus 로고    scopus 로고
    • Available from: www.ISPOR@info@ispor.org
    • ISPOR Good practices for outcomes research; International society for pharmacoeconomics and outcomes research. 2013. Available from: www.ISPOR@info@ispor.org
    • (2013) ISPOR Good Practices for Outcomes Research
  • 16
    • 34247361269 scopus 로고    scopus 로고
    • The Patient-reported outcomes measurement information system (PROMIS): Progress of a NIH roadmap cooperative group doing its first two years
    • Cella D, Yount S, Rothrock N, et al. The Patient-reported outcomes measurement information system (PROMIS): Progress of a NIH roadmap cooperative group doing its first two years. Med Care 2007;45:S3-S11
    • (2007) Med Care , vol.45 , pp. S3-S11
    • Cella, D.1    Yount, S.2    Rothrock, N.3
  • 17
    • 84876739867 scopus 로고    scopus 로고
    • Submission to the Australian commission on safety and quality in healthcare - Discussion paper submitted by the Available from
    • Patient-centred care: improving quality of life and safety by focusing care on patients and consumers. Submission to the Australian commission on safety and quality in healthcare - Discussion paper submitted by the Royal Australian & New Zealand College of Physicians. 2010. Available from: www.ranzcp.org
    • (2010) Patient-centred Care: Improving Quality of Life and Safety by Focusing Care on Patients and Consumers


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.